ABT as of Oct 31 · 12:15 ET
ABTNYSEPharmaceutical Preparations

Abbott Laboratories · Brief

Next report

82 days

Jan 21 · before openest.

Expected move

Inputs

Implied vs realized

8 reportsHistory
4 of 8≥ implied
avg implied
±3.8%
avg realized
±5.4%
Jan 22 '25±2.9%▲+0.85%×0.29
Apr 16 '25±3.3%▲+2.76%×0.84
Jul 17 '25±3.0%▼−8.52%×2.86
Oct 15 '25±4.3%▼−2.43%×0.57
Jan 22 '26±3.2%▼−10.04%×3.11
Q1 FY26±4.4%▼−6.00%×1.37
Q2 FY26±4.3%▲+10.71%×2.49
Oct 21 '26±5.3%▼−1.89%×0.36
quarterimplied−15%0+15%realized×
Oct '26±5.3%▼−1.89%×0.36
Q2 FY26±4.3%▲+10.71%×2.49
Q1 FY26±4.4%▼−6.00%×1.37
Jan '26±3.2%▼−10.04%×3.11
Oct '25±4.3%▼−2.43%×0.57
Jul '25±3.0%▼−8.52%×2.86
2 older reports
Apr '25±3.3%▲+2.76%×0.84
Jan '25±2.9%▲+0.85%×0.29
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 21 report · est.

Bull2 of 4

4customers disclosing the company as a supplierSEC filings
11tracked funds holding the companyN-PORT · Aug 31 '26

Bear2 of 3

10 of 23largest reporting managers cutting their stake in the latest quarter13F · Jun 30 '26
76concentration of reported value among managers13F · Jun 30 '26
AI captions · Oct 26 '26once per report · top 2 per case

Linked exposure

ABT report session
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 27N-PORTSCHD: ABT weight up to 4.68%.Source
Oct 7impliedImplied move: ±5.4% into Oct 21 earnings (Oct 7 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.